Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Transplanted Organ Rejection”

88 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 88 results

Testing effectiveness (Phase 2)Study completedNCT04431219
What this trial is testing

First in Human Study: LIS1, an Induction Treatment in Kidney Transplanted Patients

Who this might be right for
Kidney Transplant
Xenothera SAS 10
Not applicableNot Yet RecruitingNCT06438107
What this trial is testing

Deep Phenotyping of the Renal Allograft to Prognosticate Clinical Outcomes

Who this might be right for
Renal Transplant Rejection
University of Pittsburgh 24
Not applicableStudy completedNCT03737136
What this trial is testing

Comparison Between Bortezomib and Rituximab Plus Plasmapheresis in AMR

Who this might be right for
Antibody-mediated Rejection
Shahid Beheshti University of Medical Sciences 20
Not applicableStudy completedNCT03874299
What this trial is testing

The TOGETHER Project - Kidney RNA-seq Validation

Who this might be right for
Kidney Transplant Rejection
Mayo Clinic 302
Not applicableStudy completedNCT02382211
What this trial is testing

T-SPOT.CMV and T-SPOT.PRT Diagnostic Assays

Who this might be right for
Infection in Solid Organ Transplant Recipients
Oxford Immunotec 600
Testing effectiveness (Phase 2)Study completedNCT00076570
What this trial is testing

Combination Drug Therapy Followed by Single Drug Steroid Free Therapy to Prevent Organ Rejection in Kidney Transplantation

Who this might be right for
Kidney Transplantation
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) 31
Early research (Phase 1)Study completedNCT06090799
What this trial is testing

Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of SHR-3032 in Healthy Subjects

Who this might be right for
Prevention of Graft Rejection After Organ Transplantation
Guangdong Hengrui Pharmaceutical Co., Ltd 6
Testing effectiveness (Phase 2)UnknownNCT01154387
What this trial is testing

Evaluating Safety and Efficacy of TOL101 Induction Versus Anti-Thymocyte Globulin to Prevent Kidney Transplant Rejection

Who this might be right for
End Stage Renal DiseaseRenal Transplant
Tolera Therapeutics, Inc 85
Very early researchStudy completedNCT03626714
What this trial is testing

Safety and Pharmacokinetics of Sustained-release Depot Tacrolimus: A First-in-human Study

Who this might be right for
Organ Transplant RejectionPsoriasis
Auritec Pharmaceuticals 8
Testing effectiveness (Phase 2)Study completedNCT00734396
What this trial is testing

Mesenchymal Stem Cells and Subclinical Rejection

Who this might be right for
Organ Transplantation
Leiden University Medical Center 15
Not applicableEnded earlyNCT03439995
What this trial is testing

Goal of Open Lung Ventilation in Donors

Who this might be right for
Brain DeathOrgan DonationOrgan Transplant Failure or Rejection
Vanderbilt University Medical Center 154
Not applicableUnknownNCT01883583
What this trial is testing

Pilot Study of Contrast-Enhanced Ultrasound of Transplanted Kidney

Who this might be right for
Transplant; Failure, Kidney
Seoul National University Hospital 10
Testing effectiveness (Phase 2)Study completedNCT00001984
What this trial is testing

Effectiveness of the Investigational Drug Campath-1H in Preventing Rejection of Transplanted Kidneys

Who this might be right for
Graft RejectionKidney Disease
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) 5
Testing effectiveness (Phase 2)Enrolling By InvitationNCT05285878
What this trial is testing

Fingolimod for the Abrogation of Interstitial Fibrosis and Tubular Atrophy Following Kidney Transplantation

Who this might be right for
Interstitial FibrosisKidney Transplant; ComplicationsKidney Transplant Rejection+4 more
The Methodist Hospital Research Institute 20
Not applicableUnknownNCT03255265
What this trial is testing

Clinical Study of Microchimerism and cfDNA as Biomarkers for Acute Rejection After Organ Transplantation

Who this might be right for
Organ Transplant Rejection
Fuzhou General Hospital 950
Not applicableLooking for participantsNCT02423070
What this trial is testing

Genome Transplant Dynamics

Who this might be right for
Thoracic Organ Transplantation
National Heart, Lung, and Blood Institute (NHLBI) 991
Post-approval studies (Phase 4)Study completedNCT01212406
What this trial is testing

Vitamin D in Bronchiolitis Obliterans Syndrome

Who this might be right for
Allograft RejectionLung TransplantationBronchiolitis Obliterans
Universitaire Ziekenhuizen KU Leuven 100
Testing effectiveness (Phase 2)Study completedNCT01536379
What this trial is testing

Belimumab in the Prevention of Kidney Transplant Rejection

Who this might be right for
Transplantation, Organ
GlaxoSmithKline 30
Not applicableUnknownNCT02469207
What this trial is testing

Regenerative Cellular Therapies, Physiology, Pathology and Developmental Biology

Who this might be right for
Graft RejectionTransplantationDiabetes Mellitus
Cambridge University Hospitals NHS Foundation Trust 50
Testing effectiveness (Phase 2)Study completedNCT01394497
What this trial is testing

Use of N-Acetylcysteine During Liver Procurement

Who this might be right for
Liver FailureLiver Failure, AcuteLiver Diseases+2 more
Azienda Ospedaliera di Padova 140
Load More Results